1887

Chapter 63 : Respiratory Viruses

Authors: David J. Speicher1, Mohsin Ali2, Marek Smieja3
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Griffith University, Menzies Health Institute Queensland, Gold Coast Campus, Queensland 4222, Australia; 2: Icahn School of Medicine at Mount Sinai, Department of Medical Education, One Gustave L. Levy Place, New York, NY 10029; 3: McMaster University, Department of Pathology & Molecular Medicine, L424-St. Joseph's Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada
Content Type: Reference
Publication Year: 2016

Category: Immunology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Respiratory Viruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH63-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH63-2.gif

Abstract:

Respiratory viruses are among the most common acute viral infections affecting humans and contribute appreciably to school and to work absenteeism. Globally, acute respiratory tract infections (ARTI) cause frequent morbidity and mortality among children under the age of 5 years, and are a major health care burden (1). Among the very young and the very old, as well as those with chronic medical conditions, respiratory viruses contribute substantially to medical visits, prescription of antibiotics and antivirals, hospitalizations, and deaths.

Citation: Speicher D, Ali M, Smieja M. 2016. Respiratory Viruses, p 598-609. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch63
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818722.ch63
1. Fouchier RA, Hartwig NG, Bestebroer TM, Niemeyer B, de Jong JC, Simon JH, Osterhaus AD. 2004. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 101 : 6212– 6216.[CrossRef].[PubMed]
2. Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, Hough LJ, Obrosky DS, Schulz R, Ricci EM, Rogers JC, Kapoor WN. 1999. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 159 : 970– 980.[PubMed].[CrossRef]
3. Arden KE, Nissen MD, Sloots TP, Mackay IM. 2005. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 75 : 455– 462.[CrossRef].[PubMed]
4. Mahony JB, Petrich A, Smieja M. 2011. Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci 48 : 217– 249.[CrossRef].[PubMed]
5. Sugrue RJ, Hay AJ. 1991. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180 : 617– 624.[PubMed].[CrossRef]
6. Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, Arden KE, Nissen MD, Sloots TP. 2006. Genetic diversity of human metapneumovirus over 4 consecutive years in Australia. J Infect Dis 193 : 1630– 1633.[CrossRef].[PubMed]
7. Hamre D, Kindig DA, Mann J. 1967. Growth and intracellular development of a new respiratory virus. J Virol 1 : 810– 816.[PubMed]
8. Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD, Fouchier RA. 2004. Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42 : 981– 986.[PubMed].[CrossRef]
9. Tyrrell DA, Bynoe ML. 1965. Cultivation of a novel type of common-cold virus in organ cultures. BMJ 1 : 1467– 1470.[PubMed].[CrossRef]
10. Enserink M. 2003. Infectious diseases. Calling all coronavirologists. Science 300 : 413– 414.[CrossRef].[PubMed]
11. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. 2003. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 36 : 985– 989.[CrossRef].[PubMed]
12. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY HKU/UCH SARS Study Group. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 : 1767– 1772.[PubMed].[CrossRef]
13. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY SARS study group. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 : 1319– 1325.[PubMed].[CrossRef]
14. Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L, Soccal PM, Nicod L, Kaiser L. 2004. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 170 : 1197– 1203.[CrossRef].[PubMed]
15. Mackay IM, Arden KE, Speicher DJ, O'Neil NT, McErlean PK, Greer RM, Nissen MD, Sloots TP. 2012. Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004. Viruses 4 : 637– 653.[CrossRef].[PubMed]
16. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, Wertheim-van Dillen PM, Kaandorp J, Spaargaren J, Berkhout B. 2004. Identification of a new human coronavirus. Nat Med 10 : 368– 373.[CrossRef].[PubMed]
17. Bastien N, Robinson JL, Tse A, Lee BE, Hart L, Li Y. 2005. Human coronavirus NL-63 infections in children: a 1-year study. J Clin Microbiol 43 : 4567– 4573.[CrossRef].[PubMed]
18. Chiu SS, Chan KH, Chu KW, Kwan SW, Guan Y, Poon LL, Peiris JS. 2005. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis 40 : 1721– 1729.[CrossRef].[PubMed]
19. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, Wong BH, Poon RW, Cai JJ, Luk WK, Poon LL, Wong SS, Guan Y, Peiris JS, Yuen KY. 2005. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79 : 884– 895.[CrossRef].[PubMed]
20. Woo PC, Lau SK, Tsoi HW, Huang Y, Poon RW, Chu CM, Lee RA, Luk WK, Wong GK, Wong BH, Cheng VC, Tang BS, Wu AK, Yung RW, Chen H, Guan Y, Chan KH, Yuen KY. 2005. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 192 : 1898– 1907.[CrossRef].[PubMed]
21. Sloots TP, McErlean P, Speicher DJ, Arden KE, Nissen MD, Mackay IM. 2006. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 35 : 99– 102.[CrossRef].[PubMed]
22. Woo PC, Lau SK, Huang Y, Tsoi HW, Chan KH, Yuen KY. 2005. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch Virol 150 : 2299– 2311.[CrossRef].[PubMed]
23. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. 2005. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102 : 12891– 12896.[CrossRef].[PubMed]
24. Bialasiewicz S, Whiley DM, Lambert SB, Jacob K, Bletchly C, Wang D, Nissen MD, Sloots TP. 2008. Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. J Clin Virol 41 : 63– 68.[CrossRef].[PubMed]
25. Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3 : e64.[CrossRef].[PubMed]
26. Sloots TP, Mackay IM, Bialasiewicz S, Jacob KC, McQueen E, Harnett GB, Siebert DJ, Masters BI, Young PR, Nissen MD. 2006. Human metapneumovirus, Australia, 2001–2004. Emerg Infect Dis 12 : 1263– 1266.[CrossRef].[PubMed]
27. Granados A, Goodall EC, Luinstra K, Smieja M, Mahony J. 2015. Comparison of asymptomatic and symptomatic rhinovirus infections in university students: incidence, species diversity, and viral load. Diagn Microbiol Infect Dis 82 : 292– 296.[CrossRef].[PubMed]
28. Hatchette TF, Drews SJ, Grudeski E, Booth T, Martineau C, Dust K, Garceau R, Gubbay J, Karnauchow T, Krajden M, Levett PN, Mazzulli T, McDonald RR, McNabb A, Mubareka S, Needle R, Petrich A, Richardson S, Rutherford C, Smieja M, Tellier R, Tipples G, LeBlanc JJ. 2015. Detection of enterovirus D68 in Canadian laboratories. J Clin Microbiol 53 : 1748– 1751.[CrossRef].[PubMed]
29. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L CDC EPIC Study Team. 2015. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373 : 415– 427.[CrossRef].[PubMed]
30. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L CDC EPIC Study Team. 2015. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372 : 835– 845.[CrossRef].[PubMed]
31. Centers for Disease Control and Prevention (CDC). 2011. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60 : 1128– 1132.[PubMed]
32. Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, Aoki F, Horsman G, Van Caeseele P, Chokani K, Vooght M, Babiuk L, Webby R, Walter SD. 2010. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 303 : 943– 950.[CrossRef].[PubMed]
33. Dobson J, Whitley RJ, Pocock S, Monto AS. 2015. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385 : 1729– 1737.[CrossRef].[PubMed]
34. World Health Organization (WHO). 2015. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2015. http://www.who.int/influenza/human_animal_interface/EN_GIP_20150717cumulativeNumberH5N1cases.pdf?ua=1. Accessed 7 August 2015.
35. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch BJ, Lattwein E, Alhakeem RF, Assiri AM, Albarrak AM, Al-Shangiti AM, Al-Tawfiq JA, Wikramaratna P, Alrabeeah AA, Drosten C, Memish ZA. 2015. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15 : 559– 564.[CrossRef]
36. World Health Organization. 2015. Middle East respiratory syndrome coronavirus (MERS-CoV)–Republic of Korea. Disease outbreak news. WHO, Geneva, Switzerland. http://www.who.int/csr/don/03-july-2015-mers-korea/en/
37. Khan F. 2015. Enterovirus D68: acute respiratory illness and the 2014 outbreak. Emerg Med Clin North Am 33 : e19– e32.[PubMed].[CrossRef]
38. Smieja M, Castriciano S, Carruthers S, So G, Chong S, Luinstra K, Mahony JB, Petrich A, Chernesky M, Savarese M, Triva D. 2010. Development and evaluation of a flocked nasal midturbinate swab for self-collection in respiratory virus infection diagnostic testing. J Clin Microbiol 48 : 3340– 3342.[CrossRef].[PubMed]
39. Wurzel DF, Marchant JM, Clark JE, Mackay IM, Wang CY, Sloots TP, Upham JW, Yerkovich ST, Masters IB, Baker PJ, Anderson-James S, Chang AB. 2013. Respiratory virus detection in nasopharyngeal aspirate versus bronchoalveolar lavage is dependent on virus type in children with chronic respiratory symptoms. J Clin Virol 58 : 683– 688.[CrossRef].[PubMed]
40. Daley P, Castriciano S, Chernesky M, Smieja M. 2006. Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients. J Clin Microbiol 44 : 2265– 2267.[CrossRef].[PubMed]
41. Luinstra K, Petrich A, Castriciano S, Ackerman M, Chong S, Carruthers S, Ammons B, Mahony JB, Smieja M. 2011. Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses. J Clin Microbiol 49 : 2138– 2142.[CrossRef].[PubMed]
42. Mahony JB, Blackhouse G, Babwah J, Smieja M, Buracond S, Chong S, Ciccotelli W, O'Shea T, Alnakhli D, Griffiths-Turner M, Goeree R. 2009. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol 47 : 2812– 2817.[CrossRef].[PubMed]
43. Herman M, Smieja M, Carruthers S, Loeb M. 2014. Oseltamivir use amongst hospitalized patients infected with influenza. Influenza Other Respi Viruses 8 : 547– 548.[CrossRef]
44. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. 2012. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156 : 500– 511.[CrossRef].[PubMed]
45. Hatchette TF, Bastien N, Berry J, Booth TF, Chernesky M, Couillard M, Drews S, Ebsworth A, Fearon M, Fonseca K, Fox J, Gagnon JN, Guercio S, Horsman G, Jorowski C, Kuschak T, Li Y, Majury A, Petric M, Ratnam S, Smieja M, Van Caeseele P Pandemic Influenza Laboratory Preparedness Network. 2009. The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know. Can J Public Health 100 : 204– 207.[PubMed]
46. Rath B, Tief F, Obermeier P, Tuerk E, Karsch K, Muehlhans S, Adamou E, Duwe S, Schweiger B. 2012. Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing. J Clin Virol 55 : 329– 333.[CrossRef].[PubMed]
47. Leonardi GP, Wilson AM, Zuretti AR. 2013. Comparison of conventional lateral-flow assays and a new fluorescent immunoassay to detect influenza viruses. J Virol Methods 189 : 379– 382.[CrossRef].[PubMed]
48. Hassan F, Nguyen A, Formanek A, Bell JJ, Selvarangan R. 2014. Comparison of the BD Veritor system for Flu A+B with the Alere BinaxNOW influenza A&B card for detection of influenza A and B viruses in respiratory specimens from pediatric patients. J Clin Microbiol 52 : 906– 910.[CrossRef].[PubMed]
49. Nam MH, Jang JW, Lee JH, Cho CH, Lim CS, Kim WJ. 2014. Clinical performance evaluation of the BD Veritor system Flu A+B assay. J Virol Methods 204 : 86– 90.[CrossRef].[PubMed]
50. Dunn JJ, Ginocchio CC. 2015. Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections? J Clin Microbiol 53 : 1790– 1796.[CrossRef].[PubMed]
51. Khanom AB, Velvin C, Hawrami K, Schutten M, Patel M, Holmes MV, Atkinson C, Breuer J, Fitzsimons J, Geretti AM. 2011. Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care. J Infect 62 : 52– 58.[CrossRef].[PubMed]
52. Ratcliff RM, Chang G, Kok T, Sloots TP. 2007. Molecular diagnosis of medical viruses. Curr Issues Mol Biol 9 : 87– 102.[PubMed]
53. Centers for Disease Control and Prevention. Table 1. FDA-cleared RT-PCR Assays and Other Molecular Assays for Influenza Viruses. http://www.cdc.gov/flu/pdf/professionals/diagnosis/table1-molecular-assays.pdf. Accessed 7 August 2015.
54. Hazelton B, Gray T, Ho J, Ratnamohan VM, Dwyer DE, Kok J. 2015. Detection of influenza A and B with the Alere i Influenza A & B: a novel isothermal nucleic acid amplification assay. Influenza Other Respi Viruses 9 : 151– 154.[CrossRef]
55. Mahony J, Chong S, Merante F, Yaghoubian S, Sinha T, Lisle C, Janeczko R. 2007. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol 45 : 2965– 2970.[CrossRef].[PubMed]
56. Popowitch EB, O'Neill SS, Miller MB. 2013. Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses. J Clin Microbiol 51 : 1528– 1533.[CrossRef].[PubMed]
57. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM, Zambon M WHO Consultation on Pandemic Influenza A (H1N1) 2009 Virus Resistance to Antivirals. 2012. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 12 : 240– 248.[CrossRef].[PubMed]

Tables

Respiratory Viruses
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818722.ch63-1,webId=/content/author/10.1128/9781555818722.ch63-1,properties={foaf_givenname=David J., foaf_name=David J. Speicher, foaf_surname=Speicher, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818722.ch63-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818722.ch63-2,webId=/content/author/10.1128/9781555818722.ch63-2,properties={foaf_givenname=Mohsin, foaf_name=Mohsin Ali, foaf_surname=Ali, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818722.ch63-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818722.ch63-3,webId=/content/author/10.1128/9781555818722.ch63-3,properties={foaf_givenname=Marek, foaf_name=Marek Smieja, foaf_surname=Smieja, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818722.ch63-aff3]]}]]
Citation: Speicher D, Ali M, Smieja M. 2016. Respiratory Viruses, p 598-609. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch63
/content/10.1128/9781555818722.ch63.ch63tab1
TABLE 1

Reported ranges of sensitivity and specificity of a representative selection of influenza rapid antigen detection kits

Generic image for table
TABLE 1

Reported ranges of sensitivity and specificity of a representative selection of influenza rapid antigen detection kits

Citation: Speicher D, Ali M, Smieja M. 2016. Respiratory Viruses, p 598-609. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch63
/content/10.1128/9781555818722.ch63.ch63tab2
TABLE 2

Representative molecular assays for influenza cleared by the U.S. FDA

Generic image for table
TABLE 2

Representative molecular assays for influenza cleared by the U.S. FDA

Citation: Speicher D, Ali M, Smieja M. 2016. Respiratory Viruses, p 598-609. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch63

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error